✦ LIBER ✦

PSM1 COST-EFFECTIVENESS ANALYSIS OF CHAMPIX® (VARENICLINE) IN SMOKING CESSATION TREATMENT IN SPAIN

✍ Scribed by J F Bobadilla; M Brosa; K Wilson; C Sánchez Maestre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSM1 A LONG TERM COST–EFFECTIVENESS ANAL

✍ J Mould-Quevedo; J Saenz-Montanez; G Davila-Loaiza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PSM2 THE COST UTILITY OF VARENICLINE IN

✍ K Bolin; H Gilljam; AC Mörk; B Lindgren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PRS24 THE COST-EFFECTIVENESS ANALYSIS OF

✍ J Walczak; G Nogas; A Dybek-Karpiuk; J Augustynska; J Stelmachowski; M Garbacka; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PSM4 HEALTH ECONOMIC MODEL OF SMOKING CE

✍ A Rasch; C Lenz; W Greiner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PRS13 THE COST-EFFECTIVENESS OF VARENICL

✍ PB Poulsen; J Dollerup; H Keiding 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Cost-effectiveness of varenicline and th

✍ Harold S Javitz; Susan M Zbikowski; Mona Deprey; Timothy A McAfee; Jennifer B Mc 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 182 KB